| Literature DB >> 28182740 |
Yanhong Li1, Shanfa Yu1, Guizhen Gu1, Guoshun Chen2, Yuxin Zheng3, Jie Jiao1, Wenhui Zhou1, Hui Wu1, Zengrui Zhang1, Huanling Zhang2, Lihua He4, Qiuyue Yang4, Xiangrong Xu4.
Abstract
Noise-induced hearing loss (NIHL) is the second-most frequent form of sensorineural hearing loss. When exposed to the same noise, some workers develop NIHL while others do not, suggesting that NIHL may be associated with genetic factors. To explore the relationship between single nucleotide polymorphisms (SNPs) in heat shock protein 70 (HSP70) genes (HSPA1A, HSPA1B and HSPA1L) and susceptibility to NIHL in Han Chinese workers exposed to noise, a case-control association study was carried out with 286 hearing loss cases and 286 matched with gender, age, type of work, and exposure time, drawn from a population of 3790 noise-exposed workers. Four SNPs were selected and genotyped. Subsequently, the effects of the alleles and genotypes of the three HSP70 genes (HSPA1A, HSPA1B and HSPA1L) on NIHL were analyzed by using a conditional logistic regression. A generalized multiple dimensionality reduction (GMDR) was applied to further detect an interaction between the four SNPs. Compared with the combined genotypes CC/TC, carriers of the TT genotype of rs2763979 appeared to show greater susceptibility to NIHL (P = 0.042, adjusted OR = 1.731, 95% CI 1.021-2.935). A significant interaction between rs2763979 and CNE was found (P = 0.029), and a significant association was found between TT of s2763979 and NIHL (P = 0.024, adjusted OR = 5.694, 95%CI 1.256-25.817) in the 96 dB (A)≤CNE<101 dB (A) group. The results suggest that the rs2763979 locus of the HSP70 genes may be associated with susceptibility to NIHL in Chinese individuals, and other HSP70 genes may also be susceptibility genes for NIHL, but the results must be further replicated in additional independent sample sets.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28182740 PMCID: PMC5300111 DOI: 10.1371/journal.pone.0171722
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Comparison of the equilibrium factors in the case and control groups.
| Variables | Case | Control | |
|---|---|---|---|
| Age(yr), mean ±SD | 40.5±8.1 | 39.8±8.1 | 0.298 |
| Tenure(yr), mean ±SD | 18.9±9.1 | 18.3±8.8 | 0.382 |
| CNE, mean ±SD | 98.3±4.7 | 98.3±4.6 | 0.999 |
| Gender, n (%) | |||
| male | 274(95.8) | 274(95.8) | 1.000 |
| female | 12(4.2) | 12(4.2) | |
| Hypertension, n (%) | |||
| yes | 121(42.3) | 122(42.7) | 0.933 |
| no | 165(57.7) | 164(57.3) | |
| Smoking, n (%) | |||
| yes | 192(67.1) | 141(49.3) | |
| no | 94(32.9) | 145(50.7) | |
| Drinking, n (%) | |||
| yes | 198(69.2) | 190(66.4) | 0.474 |
| no | 88(30.8) | 96(33.6) | |
Characteristics of single nucleotide polymorphisms of genetic analysis.
| Genes | SNPs | Nucleotide change | Location | MAF(HapMap-CHB) | |
|---|---|---|---|---|---|
| HSPA1A | rs1043618 | C/G | 5'UTR | 0.311 | 0.907 |
| HSPA1B | rs2763979 | C/T | 5'_flanking | 0.333 | 0.263 |
| HSPA1L | rs2075800 | C/T | exon2 | 0.314 | 0.759 |
| rs2227956 | A/G | exon2 | 0.204 | 0.091 |
a HWE tests were performed using Pearson’s χ2 for each SNP among the control subjects.
Single SNP analysis of the association of HSP70 gene polymorphisms with the risk of NIHL.
| SNPs | Genotypes | Case(n = 286) | Control(n = 286) | Adjusted OR (95% CI) | |||
|---|---|---|---|---|---|---|---|
| N | % | N | % | ||||
| rs1043618 | GG | 124 | 43.4 | 130 | 45.5 | 1.000 | |
| GC | 117 | 40.9 | 125 | 43.7 | 0.883 | 0.973(0.677–1.399) | |
| CC | 45 | 15.7 | 31 | 10.8 | 0.207 | 1.432(0.820–2.500) | |
| GC/CC | 162 | 56.6 | 156 | 54.5 | 0.738 | 1.060(0.754–1.491) | |
| GG/GC | 241 | 84.3 | 255 | 89.2 | 1.000 | ||
| CC | 45 | 15.7 | 31 | 10.8 | 0.169 | 1.450(0.853–2.469) | |
| Additive | 0.366 | 1.122(0.874–1.440) | |||||
| G allele | 365 | 63.8 | 385 | 67.3 | 1.000 | ||
| C allele | 207 | 36.2 | 187 | 32.7 | 0.356 | 1.100(0.898–1.348) | |
| rs2763979 | CC | 104 | 36.4 | 116 | 40.6 | 1.000 | |
| TC | 133 | 46.5 | 139 | 48.6 | 0.556 | 1.124(0.763–1.656) | |
| TT | 49 | 17.1 | 31 | 10.8 | 1.859(1.042–3.315) | ||
| TC/TT | 182 | 63.6 | 170 | 59.4 | 0.253 | 1.243(0.856–1.803) | |
| CC/TC | 237 | 82.9 | 255 | 89.2 | 1.000 | ||
| TT | 49 | 17.1 | 31 | 10.8 | 1.731(1.021–2.935) | ||
| Additive | 0.059 | 1.297(0.990–1.699) | |||||
| C allele | 341 | 59.6 | 371 | 64.9 | 1.000 | ||
| T allele | 231 | 40.4 | 201 | 35.9 | 0.053 | 1.271(0.997–1.621) | |
| rs2075800 | CC | 128 | 44.8 | 112 | 39.2 | 1.000 | |
| TC | 128 | 44.8 | 132 | 46.2 | 0.323 | 0.832(0.579–1.197) | |
| TT | 30 | 10.5 | 42 | 14.7 | 0.056 | 0.576(0.328–1.013) | |
| TC/TT | 158 | 55.2 | 174 | 60.8 | 0.156 | 0.777(0.548–1.101) | |
| CC/TC | 256 | 85.9 | 244 | 85.3 | 1.000 | ||
| TT | 30 | 10.5 | 42 | 14.7 | 0.196 | 0.642(0.281–1.081) | |
| Additive | 0.061 | 0.780(0.602–1.011) | |||||
| C allele | 384 | 67.1 | 356 | 62.2 | 1.000 | ||
| T allele | 188 | 32.9 | 216 | 37.8 | 0.129 | 0.854(0.697–1.047) | |
| rs2227956 | AA | 204 | 73.9 | 201 | 72.8 | 1.000 | |
| GA | 64 | 23.2 | 73 | 26.4 | 0.455 | 0.849(0.552–1.305) | |
| GG | 8 | 2.9 | 2 | 0.7 | 0.058 | 4.784(0.949–24.113) | |
| GA/GG | 72 | 26.1 | 75 | 27.2 | 0.695 | 0.919(0.604–1.400) | |
| AA/GA | 268 | 97.1 | 274 | 99.3 | 1.000 | ||
| GG | 8 | 2.9 | 2 | 0.7 | 5.204(1.047–25.866) | ||
| Additive | 0.770 | 1.059(0.722–1.553) | |||||
| A allele | 472 | 85.5 | 475 | 86.1 | 1.000 | ||
| G allele | 80 | 14.5 | 77 | 13.9 | 0.824 | 1.033(0.779–1.368) | |
* Adjusted for blood pressure, drinking status and smoking status
Association between rs2763979 and NIHL stratified by CNE.
| CNE | Genotypes | Case(n = 286) | Control(n = 286) | Adjusted OR (95% CI) | |||
|---|---|---|---|---|---|---|---|
| N | % | N | % | ||||
| <96 | CC/TC | 85 | 85.9 | 90 | 89.1 | 0.103 | 1.000 |
| TT | 14 | 14.1 | 11 | 10.9 | 2.784(0.813–9.542) | ||
| 96–101 | CC/TC | 77 | 82.8 | 89 | 92.7 | 0.024 | 1.000 |
| TT | 16 | 17.2 | 7 | 7.3 | 5.694(1.256–25.817) | ||
| ≥101 | CC/TC | 75 | 79.8 | 76 | 85.4 | 0.351 | 1.000 |
| TT | 19 | 20.2 | 13 | 14.6 | 1.611(0.592–4.390) | ||
* Adjusted for smoking status, drinking status and hypertension status
The best combination models identified by the GMDR.
| Locus No. | Best Combination | Cross-validation consistency | Testing balanced accuracy | |
|---|---|---|---|---|
| 1 | rs2075800 | 5/10 | 0.4925 | 0.8281 |
| 2 | rs2075800,rs2227956 | 10/10 | 0.5769 | 0.0547 |
| 3 | rs2763979, rs2075800, rs2227956 | 8/10 | 0.5409 | 0.3770 |
| 4 | rs1043618, rs2763979, rs2075800,rs2227956 | 10/10 | 0.5182 | 0.3770 |
* Adjusted for blood pressure, drinking status and smoking status